STELARA 130 MG SOL DIL INFUS IV CT X 1 FA VD TRANS X 26 ML

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1123633940055
  • GGREM 514517100034103
  • Código de barras 7896212452361

O que a fonte publica

Detentor do registro
JANSSEN-CILAG FARMACEUTICA LTDA
Princípios ativos
USTEQUINUMABE
Embalagem
130 MG SOL DIL INFUS IV CT X 1 FA VD TRANS X 26 ML
Tipo de produto
Biológico
Classe terapêutica
L4C - INIBIDORES DA INTERLEUCINA

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:514517100034103
{
  "name": "STELARA 130 MG SOL DIL INFUS IV CT X 1 FA VD TRANS X 26 ML",
  "holder": "JANSSEN-CILAG FARMACEUTICA LTDA",
  "stripe": null,
  "barcodes": [
    "7896212452361"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "514517100034103",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "51.780.468/0001-87",
  "priceRegime": "Regulado",
  "productName": "STELARA",
  "productType": "Biológico",
  "hospitalOnly": true,
  "presentation": "130 MG SOL DIL INFUS IV CT X 1 FA VD TRANS X 26 ML",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "42221.86",
    "icms-12": "47979.40",
    "icms-17": "50869.70",
    "icms-18": "51490.06",
    "icms-19": "52125.76",
    "icms-20": "52777.33",
    "icms-21": "53445.40",
    "icms-22": "54130.58",
    "icms-23": "54833.57",
    "icms-17.5": "51178.00",
    "icms-19.5": "52449.51",
    "icms-20.5": "53109.27",
    "icms-22.5": "54479.84",
    "icms-12-alc": "47403.62",
    "icms-17-alc": "50259.26",
    "icms-18-alc": "50872.19",
    "icms-19-alc": "51500.24",
    "icms-20-alc": "52143.95",
    "icms-21-alc": "52804.05",
    "icms-22-alc": "53480.99",
    "icms-23-alc": "54175.54",
    "withoutTaxes": "41715.20",
    "icms-17.5-alc": "50563.84",
    "icms-19.5-alc": "51820.11",
    "icms-20.5-alc": "52471.93",
    "icms-22.5-alc": "53826.07"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "USTEQUINUMABE",
  "targetSpecies": [],
  "consumerPrices": null,
  "invalidBarcodes": [],
  "activeSubstances": [
    "USTEQUINUMABE"
  ],
  "therapeuticClass": "L4C - INIBIDORES DA INTERLEUCINA",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1123633940055",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "L4C",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:514517100034103"